Interferon alfa

Aka: Interferon alfa, Interferon-alfa

advertisement

II. Mechanism

  1. Inhibits viral replication in virus infected cells

III. Indications

  1. Hepatitis C
  2. Hepatitis B

IV. Dosing

  1. Dose: 3 MU SQ three times per week for 6-12 months

V. Efficacy

  1. Sustained response in 10-30% of cases
  2. Improved response rates with:
    1. Low levels of Viremia
    2. Absence of Cirrhosis
    3. Absence of Hepatitis CGenotype Ib
    4. Early response to Interferon
    5. Low total body iron
  3. Synergistic effect when combined with Ribavirin

VI. Adverse Effects

  1. Transient Flu-like symptoms (>50%)
    1. Fever and chills
    2. Headache
    3. Myalgia
    4. Nausea
    5. Diarrhea
  2. Initial: Decreased cell lines
    1. Decreased Granulocytes
    2. Thrombocytopenia
  3. Later
    1. Fatigue
    2. Major Depression
    3. Alopecia
    4. Rash
    5. Retinal Hemorrhages
    6. Autoimmune Thyroid disease

VII. Management of adverse effects

  1. Initial flu-like symptoms
    1. Acetaminophen (Tylenol)
  2. Hemolytic Anemia
    1. Decrease dosage or discontinue Interferon

VIII. Monitoring: Discontinue Interferon criteria

  1. Liver Function Tests not normalized by 12 weeks

IX. References

  1. Lau (1997) Gastroenterology 113:1660-7 [PubMed]
  2. (1999) Med Lett Drugs Ther 41(1054):53-4 [PubMed]

Images: Related links to external sites (from Bing)

These images are a random sampling from a Bing search on the term "Interferon alfa." Click on the image (or right click) to open the source website in a new browser window. Search Bing for all related images

Related Studies

Related Topics in Pharmacology

advertisement